Osgood, Christy L.

United States Food and Drug Administration · Center for Drug Evaluation and Research

1 paper on CoChatORCID 0000-0001-7450-9342

Most cited papers

Verified
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer
Shah, M., Osgood, C. L., Amatya, A. K., Fiero, M. H., Pierce, W. F., Nair, A., Herz, J., Robertson, K. J., Mixter, B. D., Tang, S., et al. (2022) · Clinical Cancer Research
Breast Cancer Treatment StudiesCancer Immunotherapy and Biomarkers
Cited by 105

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free